Close

Ardea Biosciences, Inc. (RDEA) Posts Q2 Loss of 68c, Wider than Views

August 5, 2011 8:32 AM EDT
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q2 loss of ($0.68), $0.16 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.69 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings